Fibromuscular dysplasia surgery
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia surgery On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia surgery |
|
Risk calculators and risk factors for Fibromuscular dysplasia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.
Overview
Revascularization by surgical intervention or percutaneous transluminal angioplasty (PTA) , are not the first-line treatment options for patients with FMD, however in cases of FMD-related RAS with signs of downstream reduction of renal function or in case of drug-resistant HTN vascular reconstruction should be considered.
Indications
there are no evidence-based guidelines and randomized, controlled trials comparing revascularization and medical therapy in patints with FMD; but ssurgery is usually reserved for patients with either:.
- HTN of recent onset with goal of cure
- drug resistance or intolerance
- renal artey dissection
- Renal artery aneurysm
- preservation of renal function or prevent renal size reduction